Abstract 89P
Background
Nasopharyngeal carcinoma (NPC) is an epithelial malignancy of the nasopharynx that raises public health concern in its endemic region due to its late diagnosis. The preclinical study of NPC and the bench-to-bed transition is challenged by the lack of appropriate NPC models. Conventional two-dimensional (2D) cell culture models fail to accurately replicate the complex three-dimensional (3D) structure and microenvironment of solid tumour while available 3D spheroid models for NPC do not take into account the interaction between different cell types.
Methods
In this study, we aimed to generate 3D multicellular tumour spheroids (MCTSs) to mimic the in vivo tumour architecture and microenvironment. Homotypic MCTSs were generated using Epstein-Barr virus (EBV)-positive (C666-1, NPC43) and EBV-negative NPC (HK-1) cell lines, respectively, while heterotypic MCTSs involve co-culturing EBV-positive and EBV-negative cells with stromal cells including fibroblasts (MRC-5) and HUVEC). Spheroids were constructed using the scaffold-based technique, and morphological examination was performed using light microscopy and fluorescence microscopy to characterize the spheroid size, shape and cellular organization.
Results
Homotypic and heterotypic MCTSs generated from EBV-positive and EBV-negative cell lines form spherical aggregates. H&E staining of the MCTSs demonstrated in vivo tumour characteristics, including 3D organisation, scanted cytoplasm, irregular and enlarged nuclei, and necrotic regions. EBV+ cell lines generally formed homotypic MCTSs with more compact and spherical morphology, while homotypic MCTSs generated from EBV- cell lines are less compact and displayed alveolar-like shape. The presence of NPC cells, fibroblasts, and endothelial cells in the heterotypic MCTSs were confirmed using immunofluorescence staining.
Conclusions
Homotypic and heterotypic MCTSs were generated from both EBV- and EBV+ NPC cells. The MCTSs generated replicates the in vivo tumour features in vitro. This model would serve as a platform for the study of intercellular interactions and evaluation of potential therapeutic responses.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Malaysia Ministry of Higher Education.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
59P - Identifying blood-based proteomic mediators of cancer-associated cachexia in non-small cell lung cancer in the TRACERx study
Presenter: Rachel Scott
Session: Cocktail & Poster Display session
Resources:
Abstract
61P - Unveiling the distinctive molecular, clinical, and prognostic features of infant acute myeloid leukemia: An analysis study of pediatric AML datasets from the Children's Oncology Group
Presenter: YU TAO
Session: Cocktail & Poster Display session
Resources:
Abstract
62P - Nomogram for predicting lung metastases in patients with papillary thyroid cancer under 55 years old
Presenter: Huiyun Yang
Session: Cocktail & Poster Display session
Resources:
Abstract
64P - Evaluating gene alterations associated with recurrence in oral cavity squamous cell carcinoma
Presenter: Amanda Reyes
Session: Cocktail & Poster Display session
Resources:
Abstract
65P - Multiplex immunofluorescence analysis of LRRC15 and the TME in early-stage lung adenocarcinoma
Presenter: Jessie Woon
Session: Cocktail & Poster Display session
Resources:
Abstract
66P - Molecular profile of triple-negative breast cancer tumours and their association with response to neoadjuvant treatment: A study using next generation sequencing
Presenter: Juan Ramón Berenguer-Marí
Session: Cocktail & Poster Display session
Resources:
Abstract
67P - Multi-institutional evaluation of interrater agreement of biomarker-drug pair rankings based on the ESMO scale for clinical actionability of molecular targets (ESCAT) and sources of discordance
Presenter: Alexandra Lebedeva
Session: Cocktail & Poster Display session
Resources:
Abstract
68P - ESR1 gene mutation in hormone receptor (HR)-positive metastatic breast cancers: An NGS-based exploratory study on Indian population
Presenter: Siddappa Shanthala
Session: Cocktail & Poster Display session
Resources:
Abstract
69P - Next generation sequencing in colorectal cancer: Association of BRAF, KRAS mutations with right sided cancers, mucinous disease, lymphovascular/perineural invasion and microsatellite instability
Presenter: Gurpreet Singh Ranger
Session: Cocktail & Poster Display session
Resources:
Abstract
70P - Increased expression of interleukin-17 receptor A (IL-17RA) promotes cancer stem-like properties, resistance to 5-fluorouracil, and the expression of ATP-binding cassette transporters in colorectal cancer cells
Presenter: Chih-Yung Yang
Session: Cocktail & Poster Display session
Resources:
Abstract